Group One Trading, L.P. Medicinova Inc Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.28 - $1.65 $1 - $1	1 New	1 $0
Q3 2021 Nov 12, 2021	SELL	$3.4 - $4.24 $32,980 - $41,128	-9,700 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$3.76 - $5.14 $35,720 - $48,830	9,500 Added 4750.0%	9,700 $41,000
Q1 2021 May 12, 2021	BUY	$4.81 - $8.74 $961 - $1,748	200 New	200 $1,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $96.1M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.